Investor · Vancouver, British Columbia, Canada
Bill Radvak
Open Bill in the network graph →Filings
64
SEC Form D
Connections
193
co-filers
Capital
$3.7M
across filings
Active
Mar 2019
to Dec 2021
Most-connected co-filers (193)
Brian J. Bayley · Vancouver, British Columbia, Canada40 sharedJohn Downes · Vancouver, British Columbia, Canada36 sharedDavid A. Castle · New York, NY33 sharedRobert B. Catell · STONY BROOK, NY32 sharedKenneth I. Mcguire · La Jolla, CA21 sharedMatthew C. Osborne · La Jolla, CA21 sharedAltegris Advisors, LLC · La Jolla, CA21 sharedOleg Popovsky · Vancouver, British Columbia, Canada20 sharedJack L. Rivkin · La Jolla, CA18 sharedJohn S. Castle · New York, NY16 sharedHarold J. Punnett · Vancouver, British Columbia, Canada10 sharedMLG Fund Manager LLC · Brookfield, WI9 sharedZarrell R. Gray · Zionsville, IN9 sharedMichael Abrams · Orem, UT9 sharedSandra Lee · Vancouver, British Columbia, Canada9 sharedWillem Van Rijn · New York, NY8 sharedWilliam Kliewer · Carlsbad, CA8 sharedAlan D. Branham · Vancouver, British Columbia, Canada8 sharedMartin C. Beaulieu · La Jolla, CA8 sharedMichael Doyle · Vancouver, British Columbia, Canada8 sharedJon C. Sundt · La Jolla, CA7 sharedWilliam Adams · Los Angeles, CA6 sharedPaul Brennan · Vancouver, British Columbia, Canada6 sharedRichard R. Halderman · Zionsville, IN6 shared
Recent filings (64)
NERVGEN PHARMA CORP.Dec 2021 · 27 co-filers$1.1MNERVGEN PHARMA CORP.Aug 2021 · 23 co-filers$5.4MNERVGEN PHARMA CORP.Aug 2021 · 23 co-filers$442KNERVGEN PHARMA CORP.Jun 2021 · 23 co-filers$650KNERVGEN PHARMA CORP.Aug 2020 · 15 co-filers$5.4MNERVGEN PHARMA CORP.Aug 2020 · 15 co-filers$5.4MAzurRx BioPharma, Inc.Jul 2020 · 22 co-filers$22.8MNERVGEN PHARMA CORP.Jun 2020 · 21 co-filers$650KKorea Value Opportunity Fund, LPFeb 2020 · 17 co-filersRegency Gold Corp.Feb 2020 · 18 co-filers$3.0MRegency Gold Corp.Feb 2020 · 18 co-filers$3.0MAzurRx BioPharma, Inc.Jan 2020 · 20 co-filers$8.0MNERVGEN PHARMA CORP.Nov 2019 · 15 co-filers$1.5MNERVGEN PHARMA CORP.Nov 2019 · 15 co-filers$1.5MNERVGEN PHARMA CORP.Mar 2019 · 13 co-filers$1.2MNERVGEN PHARMA CORP.Mar 2019 · 13 co-filers$1.2MAzurRx BioPharma, Inc.Mar 2019 · 20 co-filers$2.0MKorea Value Opportunity Fund, LPMar 2019 · 17 co-filersNERVGEN PHARMA CORP.Sep 2018 · 5 co-filers$111KAltegris Millennium Fund, Ltd.Feb 2017 · 10 co-filersAltegris Global Macro Fund, L.P.Feb 2017 · 10 co-filersALTEGRIS MULTI STRATEGY FUND LPFeb 2017 · 10 co-filersAltegris Global Macro II Fund, L.P.Oct 2016 · 13 co-filersAltegris Global Macro Fund, L.P.Aug 2016 · 13 co-filersAltegris Eckhardt Futures Fund, L.P.Aug 2016 · 13 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Bill in the interactive graph →